PDA Annual Global Conference on Pharmaceutical Microbiology 2013

The PDA 8th Annual Global Conference on Pharmaceutical Microbiology will bring together all levels of industry professionals to network and benefit from a program that reveals the essential science of microbiology and seeks to solve the problems that our industry faces on a daily basis. The comprehensive program agenda will include presentations from regulatory and industry representatives from around the world who will share recent case studies, current and future trends in the field of pharmaceutical microbiology.

During the conference, PDA will host an exhibition of leading bio/pharmaceutical companies who will showcase new technologies and trends for pharmaceutical microbiology strategies.

Learning Objectives

At the completion of this conference attendees will be able to:

• Describe the current and future role of microbiology in managing microbial risk, microbial contamination control and risk managementin aseptic and sterile manufacturing

• Discuss current and anticipated requirements in maintaining microbiological (bioburden and pyroburden) control of product components prior to sterilization and in maintaining sterility of products

• Implement appropriate strategies for maintaining a sterile manufacturing environment (the importance of microbial identification, testing for and understanding the impact ofobjectionable organisms and resolving microbial challenges associated with sterile operations)

• Summarize advances in new technologies and rapid microbiological methods, microbial identification technologies, and endotoxin testing for quality control and process control during manufacturing

• Identify local regulatory and pharmacopeial expectations

Who Should Attend

Departments: Microbiology, Compliance, Engineering, Manufacturing, QA/QC, Development, Regulatory Affairs, Research and Development, Validation

Level of Expertise: Executives, Management, Scientists/Technicians<